Key Highlights

  • XP Power (LSE:XPP) shares advanced 4.5% to 1,812p, implying a Market Capitalisation of approximately £486m.
  • H1 2026 order intake increased 55% in constant currency, producing a book-to-bill ratio of 1.53 times.
  • Semiconductor Manufacturing Equipment orders climbed 116%, with a record divisional book-to-bill ratio of 1.81 times.
  • Adjusted operating profit increased 79% to £8.6m as the adjusted gross Margin expanded to 45.9%.
  • The previous Comet damages award, attorney fees and permanent injunction were vacated, although the case has been remanded for a new trial.
  • Management maintained its full-year expectations but did not publicly state an “at least £244m” Revenue target in the interim announcement.

XP Power (LSE:XPP) was among London’s stronger performers on 26 August 2026, advancing 4.5% to 1,812p and valuing the power-control specialist at approximately £486m.

The company develops power-conversion and control products used in semiconductor manufacturing equipment, healthcare systems and industrial technology. Its products typically represent a small proportion of customers’ overall equipment costs but are critical to performance, reliability and precise power delivery.

No fresh regulatory announcement accompanied the 26 August rise. Instead, the move appears to extend the positive reaction to XP Power’s interim results published earlier in August. Those figures provided stronger evidence that the semiconductor equipment cycle is recovering and that the company’s restructuring measures are improving profitability.

What Happened to XP Power Shares?

XP Power shares rose 4.5% to 1,812p in the latest market snapshot. Based on the company’s share count, the price implies an Equity value of approximately £486m, broadly consistent with the valuation quoted in the original draft.

There was no new company announcement on 26 August that could be identified as a direct catalyst. The rise is therefore better interpreted as continued momentum following the H1 results rather than a response to a same-day development.

Investors appear to be focusing on three areas: accelerating orders, improving gross margins and reduced immediate risk from the Comet litigation. These developments have strengthened the recovery narrative after a difficult period marked by destocking, weak semiconductor demand, elevated borrowings and legal uncertainty.

However, the company must still convert its larger order book into shipments and cash. The price recovery therefore reflects improving expectations rather than a completed operational turnaround.

Latest Company Developments

XP Power’s H1 results contained the strongest order indicators reported by the Business for several years.

Order intake reached £167.2m, increasing 48% on a reported basis and 55% in constant currency. The book-to-bill ratio rose to 1.53 times from 1.02 times, its highest level since the first half of 2022.

Momentum also strengthened as the half progressed. Orders increased from £79.1m in the first quarter to £88.1m in the second, suggesting that the recovery was not limited to one short period.

The Semiconductor Manufacturing Equipment division led the improvement. Order intake reached £79.9m, representing constant-currency growth of 116%, while the book-to-bill ratio rose to a record 1.81 times. Demand was particularly strong for technically complex power solutions serving artificial-intelligence infrastructure, advanced logic chips and high-bandwidth memory.

Industrial Technology generated order intake of £59.5m and a book-to-bill ratio of 1.33 times. Healthcare orders improved to £27.8m, producing a ratio of 1.36 times. The broad divisional improvement suggests that customer destocking has largely ended, although revenue trends remain uneven.

Financial Performance

XP Power reported H1 revenue of £109.1m, compared with £110.9m a year earlier—not £111.1m as stated in the original draft. Revenue declined 2% at reported exchange rates but increased 2% in constant currency.

Adjusted gross margin expanded by 450 basis points to 45.9% from 41.4%. Statutory gross margin reached 45.8%. The improvement reflected the closure of the Chinese manufacturing facility, production transfers to Vietnam, better efficiency and a more attractive product mix.

Adjusted operating profit increased 79% to £8.6m from £4.8m, with the adjusted Operating Margin rising to 7.9% from 4.3%. Statutory operating profit more than doubled to £5.3m, while statutory profit before tax reached £2m against a £1.4m loss a year earlier.

Adjusted diluted Earnings increased to 14.2p per share from 0.4p. The statutory diluted result improved to earnings of 3.6p from a loss of 7.2p.

Cash performance was less favourable because XP Power invested ahead of expected second-half growth. Inventory increased to £73.8m from £57m as the group purchased raw materials and expanded semi-finished stock. Adjusted Operating Cash Flow fell to £8.4m, while free cash flow was negative £7.6m.

Net Debt increased from £41.5m at the end of 2025 to £47.7m at June 2026. Nevertheless, net debt was lower than the £57.9m reported a year earlier. Leverage stood at 1.3 times adjusted EBITDA and is expected to approach 1.0 times by year-end.

Order Book Supports Second-Half Growth

XP Power’s closing order book increased by £58.1m during the first half to £173.9m. Of that amount, £135m was scheduled for delivery during the second half of 2026.

This provides substantial revenue visibility, but it does not eliminate execution risk. The company must expand output quickly enough to meet customer requirements without sacrificing quality, delivery performance or margins.

Production capacity in Vietnam is being increased, while the new Malaysian factory is expected to enter full production during the fourth quarter. The pace at which these facilities ramp up will be a major determinant of second-half revenue.

The original draft referred to full-year revenue guidance of “at least £244m.” XP Power’s interim announcement did not publicly provide that precise revenue floor. It stated that full-year expectations were unchanged and that the order book supported robust second-half growth. The £244m figure should therefore be described as an external forecast, if retained, rather than formal company guidance.

The Comet Litigation

XP Power received an important legal reprieve on 14 July 2026 when the US Court of Appeals reversed the earlier District Court judgment in its dispute with Comet Technologies.

The previous award included approximately $40m in compensatory and punitive damages, together with more than $19m in attorney fees and pre-judgment interest. The permanent injunction was also vacated.

However, the litigation has not ended. The appellate court remanded the case for a new trial, meaning that XP Power could still face further legal expense and an adverse outcome.

The cash supporting the previous awards remains outside the group in a bond lodged with the District Court. Management’s year-end leverage expectation does not assume that this cash will be released, making the deleveraging target less dependent on an immediate litigation benefit.

The Growth Story

The semiconductor capital-investment cycle is the most important driver of XP Power’s recovery.

The company’s products are designed into wafer-fabrication equipment used for etching, deposition, ion implantation and inspection. Once selected for a customer programme, XP Power can generate revenue over a typical product life of five to seven years.

Demand for artificial-intelligence computing, advanced logic and high-bandwidth memory is encouraging chipmakers to expand production capacity. This, in turn, supports demand for the manufacturing equipment containing XP Power’s technology.

The business also has exposure to industrial automation, analytical equipment and advanced healthcare technologies. Approximately one-third of group revenue comes from customised technology solutions, which typically offer stronger margins and deeper customer relationships than standard products.

Management’s longer-term financial framework targets organic growth of approximately 10%, an adjusted operating margin of around 20% and leverage between zero and one times adjusted EBITDA. Current profitability remains well below that margin ambition, leaving meaningful upside if the company can increase revenue without rebuilding its cost base at the same rate.

Risks Investors Should Watch

Semiconductor cyclicality remains the principal risk. Strong ordering can be followed by delayed deliveries, customer inventory corrections or lower Capital Expenditure if chipmakers reassess their capacity requirements.

Manufacturing execution is another concern. Vietnam must increase production quickly, while Malaysia must move successfully from commissioning into commercial output. Any ramp-up problem could delay revenue and increase costs.

Additional risks include:

  • Customers placing orders earlier than usual, potentially exaggerating near-term demand.
  • Higher electronic-component costs as Supply chains tighten.
  • Exposure to a relatively concentrated group of semiconductor equipment manufacturers.
  • Foreign-exchange movements, particularly between sterling and the US dollar.
  • Negative free cash flow during the capacity-investment phase.
  • The possibility of renewed damages or legal costs from the Comet retrial.
  • Continuing Dividend suspension until leverage moves closer to the group’s target range.

XP Power’s financial position has improved, but the company is still prioritising debt reduction over Shareholder distributions.

What Could Drive the Shares Next?

The most important near-term test is the conversion of the £135m of scheduled second-half orders into revenue. Strong delivery would validate the order recovery and demonstrate that XP Power’s manufacturing network can handle higher demand.

Further margin expansion would also support the shares, particularly if production growth produces better fixed-cost absorption without creating significant inefficiencies.

Investors will monitor whether leverage approaches 1.0 times adjusted EBITDA by year-end. Reaching that level could bring the Balance Sheet closer to the board’s required position for considering dividend reinstatement.

Other potential catalysts include successful commissioning of the Malaysian factory, the sale of the former Chinese manufacturing site and a favourable resolution of the Comet case.

Conversely, order deferrals, manufacturing bottlenecks or renewed semiconductor weakness could quickly challenge the recovery narrative.

The Bottom Line

XP Power’s 4.5% rise to 1,812p reflects a recovery case that has become materially stronger. H1 orders increased sharply, semiconductor demand accelerated and margins improved despite broadly stable reported revenue.

The company also secured an important Reversal in the Comet case, although the dispute remains unresolved because a new trial has been ordered. Meanwhile, working-capital Investment and negative free cash flow show that fulfilling the expanding order book will require disciplined execution.

The direction of travel is encouraging, but the next stage depends on converting demand into shipments, profit and cash. If XP Power delivers that conversion while reducing leverage, the recovery could gain further credibility.